European equities traded in the US as American depositary receipts were rallying late Friday morning, rising 0.98% to 1,367.20 on the S&P Europe Select ADR Index, but were still down 1.4% for the week.
From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and semiconductor company Sequans Communications (SQNS), which rose 5.8% and 3.3%, respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which were up 2.4% and 2.1%, respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm BioNTech (BNTX), which fell 4.7% and 1.4%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and internet advertising firm Criteo (CRTO), which were off 0.8% and 0.7%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Silence Therapeutics (SLN), which increased 5.4% and 3.6%, respectively. They were followed by financial services company Lloyds Banking Group (LYG) and biopharmaceutical company Amarin Corporation (AMRN), which rose 2.9% and 2.8%, respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB), which fell 3.4%, followed by biopharmaceutical company Akari Therapeutics (AKTX) and cruise line operator Carnival (CUK) were off 0.2% and 0.1%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。